Loading…

Sustained viral activity of epstein-barr virus contributes to cellular immortalization of lymphoblastoid cell lines

EBV-transformed lymphoblastoid cell lines (LCLs) are used as a resource for human genetic, immunological, and pharmacogenomic studies. We investigated the biological activity of 20 LCL strains during continuous long-term subculture up to a passage number of 160. Out of 20 LCL strains, 17 proliferate...

Full description

Saved in:
Bibliographic Details
Published in:Molecules and cells 2009, 27(2), , pp.143-148
Main Authors: Jeon, J.P. (Korea Center for Disease Control and Prevention, Seoul, Republic of Korea), Nam, H.Y. (Korea Center for Disease Control and Prevention, Seoul, Republic of Korea), Shim, S.M. (Korea Center for Disease Control and Prevention, Seoul, Republic of Korea), Han, B.G. (Korea Center for Disease Control and Prevention, Seoul, Republic of Korea), E-mail: bokghee@yahoo.com
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:EBV-transformed lymphoblastoid cell lines (LCLs) are used as a resource for human genetic, immunological, and pharmacogenomic studies. We investigated the biological activity of 20 LCL strains during continuous long-term subculture up to a passage number of 160. Out of 20 LCL strains, 17 proliferated up to a passage number of 160, at which point LCLs are generally considered as "immortalized". The other three LCL strains lost the ability to proliferate at an average passage number of 41, during which these LCLs may have undergone cellular crisis. These non-immortal LCL strains exhibited no telomerase activity, decreased EBV gene expression, and a lower copy number of the EBV genome and mitochondrial DNA when compared with immortal LCLs. Thus, this study suggests that sustained EBV viral activity as well as telomerase activity may be required for complete LCL immortalization.
ISSN:1016-8478
0219-1032
DOI:10.1007/s10059-009-0018-y